Benefit Corporation: a path to affordable gene therapies?

Source: Nature Medicine

Author: Alain Fischer, Mathias Dewatripont, Michel Goldman

Categories: Article, English, Research, Restricted access

Tags: Benefit Corporation, Critiques

The following content is accessible for members only, please sign in.
Loading...
Upcoming Events
• Q4 B Academics Research Committee Meeting
• Global Event 2024: LATAM
Past Event
• B Impact Teams Webinar
• B Impact Teams Conversation Series
• B Academics Teaching Roundtable 2024
• Chat with the Board Series: The Evolution of the Standards
• Research Committee Reading Group
• BLD SE Lunch Event
Support B Academics

Our organization is able to continue its mission because of your support and generosity.
By contributing to B Academics, you’ll help ensure that our work continues.